Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ono Pharmaceutical Company, Ltd.

https://www.ono-pharma.com

Latest From Ono Pharmaceutical Company, Ltd.

Repare Gets Cash And Validation In DNA Damage Repair Alliance With Roche

Roche is paying $125m upfront to in-license potential blockbuster lead candidate camonsertib from Repare, which calls it a best-in-class ATR inhibitor and has the chance to opt back in on US commercialization.

Deals Business Strategies

Fear of Unpredictability: Industry Criticises Japan’s Frequent Pricing Rule Changes

While Japan enters annual drug price revisions with frequent regulation changes, several major corporate players in the country warn again that government policies mean that the country is at risk of “losing attractiveness.”

Japan Policy

Prestige Consumer Supply Chain Prowess Helps Offset Inflationary Pressures For Record Results

After a company-record FY2022, Prestige CEO Ron Lombardi says future inflationary pressures and supply chain issues should be “manageable.”

Sales & Earnings Companies

Finance Watch: Tessera Secures $300m-Plus To Write New Genes

Private Company Edition: In other venture capital mega-rounds, Aurion brought in $120m, Sionna launched with $111m and Irish firm Renexxion said a private equity group committed up to $100m in total investment to be made within 36 months of a future public listing. 

Financing Innovation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Generic Drugs
  • Other Names / Subsidiaries
    • Ono Pharma Korea Co., Ltd., Ono Venture Investment Fund I, L.P., Ono Venture Investment, Inc., Ono Pharma UK Ltd.
    • Ono Pharmaceutical Co., Ltd.
    • Ono Pharma Taiwan Co., Ltd.
UsernamePublicRestriction

Register